Company profile
Innate Pharma S.A.
Pipeline8 assets
- LacutamabKIR3DL2 / Monoclonal antibody / OncologySézary syndromeMycosis fungoidesCutaneous T cell lymphomas
- IPH4502IPH4502 / Nectin-4 / Antibody-drug conjugate (ADC) / OncologySolid tumors
- MonalizumabNKG2A / Monoclonal antibody / OncologyNon-small cell lung cancer (NSCLC)
- IPH6501IPH6501 / CD20 / NK cell engager (ANKET) / OncologyB-cell Non-Hodgkin's Lymphoma
- IPH6101IPH6101 / CD123 / NK cell engager (ANKET) / Oncology / AutoimmuneHematologic malignanciesAutoimmune indications
- IPH6401IPH6401 / BCMA / NK cell engager (ANKET) / OncologyMultiple myeloma
- IPH5201IPH5201 / CD39 / Monoclonal antibody / OncologySolid tumors
- IPH5301IPH5301 / CD73 / Monoclonal antibody / OncologySolid tumors